Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia

DI van der Lee; RM Reijmers; M W Honders; RS Hagedoorn; RCM de Jong; MGD Kester; DM van der Steen; AH de Ru; C Kweekel; Ilona Bijen; I Jedema; H Veelken; PA van Veelen; MHM Heemskerk; JHF Falkenburg; M Griffioen

doi:10.1172/jci97482

Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia

DI van der Lee, RM Reijmers, M W Honders, RS Hagedoorn, RCM de Jong, MGD Kester, DM van der Steen, AH de Ru, C Kweekel, Ilona Bijen, I Jedema, H Veelken, PA van Veelen, MHM Heemskerk, JHF Falkenburg, M Griffioen

Erasmus MC other

Research output: Contribution to journal › Article › Academic › peer-review

152 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	774-785
Number of pages	12
Journal	Journal of Clinical Investigation
Volume	129
Issue number	2
DOIs	https://doi.org/10.1172/jci97482
Publication status	Published - 2019

Research programs

EMC OR-01

Access to Document

10.1172/jci97482

http://hdl.handle.net/1765/114988

Cite this

van der Lee, DI., Reijmers, RM., Honders, M. W., Hagedoorn, RS., de Jong, RCM., Kester, MGD., van der Steen, DM., de Ru, AH., Kweekel, C., Bijen, I., Jedema, I., Veelken, H., van Veelen, PA., Heemskerk, MHM., Falkenburg, JHF., & Griffioen, M. (2019). Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia. Journal of Clinical Investigation, 129(2), 774-785. https://doi.org/10.1172/jci97482

@article{133519043b684b03b4981018c907155d,

title = "Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia",

author = "\{van der Lee\}, DI and RM Reijmers and Honders, \{M W\} and RS Hagedoorn and \{de Jong\}, RCM and MGD Kester and \{van der Steen\}, DM and \{de Ru\}, AH and C Kweekel and Ilona Bijen and I Jedema and H Veelken and \{van Veelen\}, PA and MHM Heemskerk and JHF Falkenburg and M Griffioen",

year = "2019",

doi = "10.1172/jci97482",

language = "Undefined/Unknown",

volume = "129",

pages = "774--785",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "American Society for Clinical Investigation",

number = "2",

}

van der Lee, DI, Reijmers, RM, Honders, MW, Hagedoorn, RS, de Jong, RCM, Kester, MGD, van der Steen, DM, de Ru, AH, Kweekel, C, Bijen, I, Jedema, I, Veelken, H, van Veelen, PA, Heemskerk, MHM, Falkenburg, JHF & Griffioen, M 2019, 'Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia', Journal of Clinical Investigation, vol. 129, no. 2, pp. 774-785. https://doi.org/10.1172/jci97482

TY - JOUR

T1 - Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia

AU - van der Lee, DI

AU - Reijmers, RM

AU - Honders, M W

AU - Hagedoorn, RS

AU - de Jong, RCM

AU - Kester, MGD

AU - van der Steen, DM

AU - de Ru, AH

AU - Kweekel, C

AU - Bijen, Ilona

AU - Jedema, I

AU - Veelken, H

AU - van Veelen, PA

AU - Heemskerk, MHM

AU - Falkenburg, JHF

AU - Griffioen, M

PY - 2019

Y1 - 2019

U2 - 10.1172/jci97482

DO - 10.1172/jci97482

M3 - Article

SN - 0021-9738

VL - 129

SP - 774

EP - 785

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 2

ER -